{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T18:20:06Z","timestamp":1790101206506,"version":"4.0.1"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.juro.2017.11.113","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T14:25:04Z","timestamp":1512656704000},"page":"1459-1463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men"],"prefix":"10.1097","volume":"199","author":[{"given":"Sanoj","family":"Punnen","sequence":"first","affiliation":[{"name":"Department of Urology, University of Miami and Miami Veterans Affairs Medical Center, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Los Angeles, California"},{"name":"Durham Veterans Affairs Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Polascik","sequence":"additional","affiliation":[{"name":"Durham Veterans Affairs Medical Center, Durham, North Carolina"},{"name":"Duke Cancer Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Loeb","sequence":"additional","affiliation":[{"name":"Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Risk","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Minnesota and Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Savage","sequence":"additional","affiliation":[{"name":"Medical University of South Carolina and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad C.","family":"Mathur","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine Service, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Uchio","sequence":"additional","affiliation":[{"name":"Department of Urology, University of California-Irvine, Irvine, California"},{"name":"Veterans Affairs Long Beach Health System, Long Beach, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Dong","sequence":"additional","affiliation":[{"name":"OPKO Diagnostics, Woburn, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Silberstein","sequence":"additional","affiliation":[{"name":"Tulane University School of Medicine and Southeast Louisiana Veterans Health Care Center, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.11.113_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.113_bib2","doi-asserted-by":"crossref","first-page":"djv095","DOI":"10.1093\/jnci\/djv095","article-title":"Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study","volume":"107","author":"Bryant","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2017.11.113_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.eururo.2015.04.028","article-title":"A four-kallikrein panel predicts high-grade cancer on biopsy: independent validation in a community cohort","volume":"69","author":"Braun","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.113_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2015.01.009","article-title":"Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: a nested case-control study","volume":"68","author":"Stattin","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.11.113_bib5","first-page":"231","article-title":"The 4Kscore\u00ae test reduces prostate biopsy rates in community and academic urology practices","volume":"17","author":"Konety","year":"2015","journal-title":"Rev Urol"},{"key":"10.1016\/j.juro.2017.11.113_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-6-19","article-title":"A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in G\u00f6teborg, Sweden","volume":"6","author":"Vickers","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.juro.2017.11.113_bib7","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/cncr.25010","article-title":"Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen","volume":"116","author":"Vickers","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2017.11.113_bib8","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2009.24.1968","article-title":"Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication","volume":"28","author":"Vickers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2017.11.113_bib9","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1158\/1078-0432.CCR-10-0122","article-title":"A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam","volume":"16","author":"Vickers","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2017.11.113_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.bjc.6605815","article-title":"A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands","volume":"103","author":"Gupta","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.juro.2017.11.113_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-10-1003","article-title":"A panel of kallikrein marker predicts prostate cancer in a large, population-based cohort followed for 15 years without screening","volume":"20","author":"Vickers","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"10.1016\/j.juro.2017.11.113_bib12","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/1471-2407-10-635","article-title":"A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France","volume":"10","author":"Benchikh","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.juro.2017.11.113_bib13","first-page":"3","article-title":"Finding the wolf in sheep's clothing: the 4Kscore is a novel blood test that can accurately identify the risk of aggressive prostate cancer","volume":"17","author":"Punnen","year":"2015","journal-title":"Rev Urol"},{"key":"10.1016\/j.juro.2017.11.113_bib14","series-title":"The Black Population: 2010. 2010 Census Briefs","author":"Rastogi","year":"2012"},{"key":"10.1016\/j.juro.2017.11.113_bib15","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3322\/caac.21340","article-title":"Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.juro.2017.11.113_bib16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJM199608013350502","article-title":"Age-specific reference ranges for serum prostate-specific antigen in black men","volume":"335","author":"Morgan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2017.11.113_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.urology.2015.12.004","article-title":"Prostate Health Index (PHI) predicts high-stage pathology in African American Men","volume":"90","author":"Schwen","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.11.113_bib18","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.juro.2016.04.075","article-title":"Clinical use of PCA3 and TMPRSS2:ERG urinary biomarkers in African-American Men undergoing prostate biopsy","volume":"196","author":"Feibus","year":"2016","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717780329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717780329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.11.113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T14:26:59Z","timestamp":1719671219000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.11.113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1016\/j.juro.2017.11.113"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.11.113","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.11.113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}